Market cap
₹5 Cr
Revenue (TTM)
₹4 Cr
P/E Ratio
--
P/B Ratio
-0.3
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-3 Cr
-
ROE
0 %
-
ROCE
-11.7 %
-
Industry P/E
--
-
EV/EBITDA
-31.7
-
Debt to Equity
-2.2
-
Book Value
₹-0.4
-
EPS
₹-0.1
-
Face value
1
-
Shares outstanding
534,171,427
9 Years Aggregate
CFO
₹-114.08 Cr
EBITDA
₹-7.79 Cr
Net Profit
₹-164.70 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Farmax India
| -- | -- | -- | -- | -50.0 | -34.0 | -- |
|
BSE Sensex*
| -9.1 | -1.2 | 2.9 | -3.6 | 5.7 | 6.2 | 10.5 |
|
BSE FMCG#
| -12.9 | -5.0 | -3.9 | -14.8 | -1.9 | 4.0 | 7.1 |
|
Company
|
2016
|
2015
|
2014
|
|---|---|---|---|
|
Farmax India
| -66.7 | -77.8 | 250.0 |
|
BSE Sensex
| 1.9 | -5.0 | 29.9 |
|
BSE FMCG
| 3.3 | 1.4 | 18.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Farmax India
|
0.1 | 4.8 | 4.4 | -2.8 | -44.6 | 0 | -- | -0.3 |
| 474.1 | 6,214.2 | 1,239.6 | 223.0 | 19.9 | 31.9 | 27.9 | 7.5 | |
| 364.0 | 16,019.6 | 3,914.6 | 753.5 | 20.4 | 25.9 | 21.4 | 5.2 | |
| 293.4 | 700.9 | 104.9 | 13.4 | -- | 45.4 | 34.1 | -- | |
| 203.5 | 7,454.5 | 2,966.5 | 284.0 | 11.0 | 18.8 | 26.2 | 4.6 | |
| 337.3 | 509.5 | 229.8 | -97.3 | -29.8 | -- | -- | -2.9 | |
| 53.0 | 102.7 | 452.3 | 10.8 | 2.7 | 28 | 9.5 | 2.3 | |
| 86.7 | 217.9 | 420.5 | 45.2 | 1.0 | 23.1 | 4.8 | 1.0 | |
| 442.2 | 1,019.4 | 107.5 | 16.0 | -- | 29.6 | 35.8 | 6.9 | |
| 530.4 | 16,803.7 | 4,537.1 | 188.2 | 8.8 | 4 | 89.3 | 2.8 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Farmax India
Manufacture of grain mill products, starches and starch products
-
Incorporated
1995
-
Chairman
--
-
Managing Director
M Srinivasa Reddy
-
Headquarters
Rangareddy Dist, Telangana
-
Website
FAQs for Farmax India
What is the current share price of Farmax India Ltd Today?
The share price of Farmax India Ltd is ₹0.05 (NSE) and ₹0.09 (BSE) as of 02-Jul-2018 IST. Farmax India Ltd has given a return of -50% in the last 3 years.
What is the current PB & PE ratio of Farmax India Ltd?
Since, TTM earnings of Farmax India Ltd is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2017 |
0.00 |
-0.26 |
2016 |
0.00 |
-0.52 |
2015 |
0.00 |
-4.79 |
2014 |
0.00 |
-0.76 |
2013 |
0.00 |
-1.49 |
What is the 52 Week High and Low of Farmax India Ltd?
The 52-week high and low of Farmax India Ltd are Rs -- and Rs -- as of 31-Aug-2026.
What is the market cap of Farmax India Ltd?
Farmax India Ltd has a market capitalisation of ₹ 5 Cr as on 07-Mar-2017. As per SEBI classification, it is a company.
Should I invest in Farmax India Ltd?
Before investing in Farmax India Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.